Patrick Arensdorf: Founder and CEO of Exai Bio
Pat Arensdorf, founder and CEO of Exai Bio, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Exai is working to develop a next-generation RNA-based platform to deliver actionable insight into cancer biology from a simple blood draw.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.